# Cohort Study of Pioglitazone and Bladder Cancer in Patients With Type II Diabetes

> **NCT01637935** · — · COMPLETED · sponsor: **Takeda** · enrollment: 193099 (actual)

## Conditions studied

- Diabetes
- Bladder Cancer

## Interventions

- **DRUG:** Pioglitazone

## Key facts

- **NCT ID:** NCT01637935
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 193099 (ACTUAL)
- **Last updated:** 2018-03-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01637935

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01637935, "Cohort Study of Pioglitazone and Bladder Cancer in Patients With Type II Diabetes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01637935. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*